Atossa Therapeutics Stock (NASDAQ: ATOS) stock price, news, charts, stock research, profile.
Open | $1.46 |
Close | - |
Volume / Avg. | 542.01K / 1.33M |
Day Range | 1.40 - 1.48 |
52 Wk Range | 0.62 - 2.31 |
Market Cap | $187.38M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 8.18% |
Days to Cover | 3.57 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Atossa Therapeutics (NASDAQ:ATOS) through any online brokerage.
Other companies in Atossa Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE) and Adverum Biotechnologies (NASDAQ:ADVM).
There is no analysis for Atossa Therapeutics.
Atossa Therapeutics has a consensus price target of $6.13.
The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $1.415 last updated Today at July 24, 2024 at 2:37 PM EDT.
There are no upcoming dividends for Atossa Therapeutics.
Atossa Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Atossa Therapeutics.
Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.